EX-10.1
Amneal Pharmaceuticals, Inc.
Execution Version 1 4896-6230-8791.1 AMENDMENT NO. 3 TO TERM LOAN CREDIT AGREEMENT AMENDMENT NO. 3 TO TERM LOAN CREDIT AGREEMENT, dated as of August 3, 2026 (this “Amendment”), to the Term Loan Credit Agreement, dated as of November 14, 2023 (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Existing Credit Agreement”; as amended by this Amendment and further defined below, the “Amended Credit Agreement”), by and among AMNEAL PHARMACEUTICALS LLC, a Delaware limited liability company (the “Borrower”), the Lenders from time to time party thereto and JPMORGAN CHASE BANK, N.A., as administrative agent and collateral agent (in such capacities, the “Administrative Agent”). W I T N E S S E T H: WHEREAS, the Borrower wishes to (i) incur Refinancing Term Loans pursuant to Section 2.19 of the Existing Credit Agreement (the “Amendment No. 3 Term Loans”), the proceeds of which will be used to refinance all of the Amendment No. 2 Term Loans outstanding under the Existing Credit Agreement immediately prior to the Amendment No. 3 Effective Dat
…